|
MOST READ |
(For the last 6-month published articles)
|
INDEXED IN |
|
|
  |
|
QUICK LINKS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE STATISTICS |
|
Submission to First Decision |
|
35 Days |
|
Acceptance Rate |
|
26% |
|
Acceptance to Publication |
|
28 Days |
|
*Average article statistics from the last 12 months data |
|
COVID-19 RESEARCH |
|
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers, the post COVID-19 condition (or long COVID) includes long term symptoms which may persist for months or years after SARS-CoV-2 infection. We will consider submissions related to all aspects of COVID-19 and Long COVID, and process the manuscripts in priority. |
| Viability Profiles of Normal and Cancer Bladder Cells With Metformin, Nitrate and Adenosine Monophosphate-Activated Protein Kinase Inhibitor | Abstract HTML PDF |
| Haitham Abdelmoaty, Sonya Good, Tuan Phan | |
| doi: https://doi.org/10.14740/wjon1590 |
